Justices Advised To Keep Law Clear In 'Skinny Label' Case
Several intellectual property groups have urged the U.S. Supreme Court to use a case involving "skinny labels" on generic drugs to set clear guidelines on what constitutes induced patent infringement, saying...To view the full article, register now.
Already a subscriber? Click here to view full article